HEADER ANTIVIRAL PROTEIN 15-JUN-01 1JE4 TITLE SOLUTION STRUCTURE OF THE MONOMERIC VARIANT OF THE CHEMOKINE MIP-1BETA COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE INFLAMMATORY PROTEIN 1-BETA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MIP-1BETA, T-CELL ACTIVATION PROTEIN 2, ACT-2, LYMPHOCYTE COMPND 5 ACTIVATION GENE-1 PROTEIN, LAG-1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET32 KEYWDS MIP-1BETA, CHEMOKINE, MACROPHAGE INFLAMMATORY PROTEIN, ANTIVIRAL KEYWDS 2 PROTEIN EXPDTA SOLUTION NMR MDLTYP MINIMIZED AVERAGE AUTHOR S.KIM,S.JAO,J.S.LAURENCE,P.J.LIWANG REVDAT 3 27-OCT-21 1JE4 1 REMARK SEQADV REVDAT 2 24-FEB-09 1JE4 1 VERSN REVDAT 1 03-OCT-01 1JE4 0 JRNL AUTH S.KIM,S.JAO,J.S.LAURENCE,P.J.LIWANG JRNL TITL STRUCTURAL COMPARISON OF MONOMERIC VARIANTS OF THE CHEMOKINE JRNL TITL 2 MIP-1BETA HAVING DIFFERING ABILITY TO BIND THE RECEPTOR JRNL TITL 3 CCR5. JRNL REF BIOCHEMISTRY V. 40 10782 2001 JRNL REFN ISSN 0006-2960 JRNL PMID 11535053 JRNL DOI 10.1021/BI011065X REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.S.LAURENCE,C.BLANPAIN,J.W.BURGNER,M.PARMENTIER,P.J.LIWANG REMARK 1 TITL CC CHEMOKINE MIP-1BETA CAN FUNCTION AS A MONOMER AND DEPENDS REMARK 1 TITL 2 ON PHE13 FOR RECEPTOR BINDING REMARK 1 REF BIOCHEMISTRY V. 39 3401 2000 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI9923196 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.J.LODI,D.S.GARRETT,J.KUSZEWSKI,M.L.TSANG,J.A.WEATHERBEE, REMARK 1 AUTH 2 W.J.LEONARD,A.M.GRONENBORN,G.M.CLORE REMARK 1 TITL HIGH-RESOLUTION SOLUTION STRUCTURE OF THE BETA CHEMOKINE REMARK 1 TITL 2 HMIP-1BETA BY MULTIDIMENSIONAL NMR REMARK 1 REF SCIENCE V. 263 1762 1994 REMARK 1 REFN ISSN 0036-8075 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRPIPE, CNS 1.0 REMARK 3 AUTHORS : DELAGLIO (NMRPIPE), BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STRUCTURE IS BASED ON A TOTAL 940 RESTRAINTS, 851 REMARK 3 DISTANCE CONSTRAINTS, 69 DIHEDRAL ANGLE RESTRAINTS, 20 DISTANCE REMARK 3 RESTRAINTS FOR 10 HYDROGEN BONDS. REMARK 4 REMARK 4 1JE4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUN-01. REMARK 100 THE DEPOSITION ID IS D_1000013670. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 2.5 REMARK 210 IONIC STRENGTH : 20MM SODIUM PHOSPHATE REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1-2MM MIP-1B F13A U-15N, 13C; REMARK 210 20MM NA-PHOSPHATE BUFFER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D_13C-SEPARATED_NOESY; 3D_15N REMARK 210 -SEPARATED_NOESY; HNHA REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS 1.0 REMARK 210 METHOD USED : THE INITIAL FOLD WAS OBTAINED BY REMARK 210 DISTANCE GEOMETRY AND FURTHER REMARK 210 REFINED BY SIMULATED ANNEALING. REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 3D 15N OR 13C REMARK 210 EDITED NMR EXPERIMENTS. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 6 58.19 -147.62 REMARK 500 ALA A 10 32.26 -165.58 REMARK 500 ALA A 17 37.86 -97.14 REMARK 500 PHE A 24 30.74 -97.26 REMARK 500 VAL A 26 -64.25 -90.03 REMARK 500 SER A 32 -170.09 -60.33 REMARK 500 ASP A 53 109.08 -57.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HUM RELATED DB: PDB REMARK 900 1HUM IS THE DIMERIC MIP-1BETA WILD-TYPE PROTEIN. REMARK 900 RELATED ID: 1VMP RELATED DB: PDB REMARK 900 1VMP BINDS TO CCR5 WHICH IS A NATURAL RECEPTOR OF MIP-1BETA. DBREF 1JE4 A 1 69 UNP P13236 CCL4_HUMAN 24 92 SEQADV 1JE4 ALA A 13 UNP P13236 PHE 36 ENGINEERED MUTATION SEQRES 1 A 69 ALA PRO MET GLY SER ASP PRO PRO THR ALA CYS CYS ALA SEQRES 2 A 69 SER TYR THR ALA ARG LYS LEU PRO ARG ASN PHE VAL VAL SEQRES 3 A 69 ASP TYR TYR GLU THR SER SER LEU CYS SER GLN PRO ALA SEQRES 4 A 69 VAL VAL PHE GLN THR LYS ARG SER LYS GLN VAL CYS ALA SEQRES 5 A 69 ASP PRO SER GLU SER TRP VAL GLN GLU TYR VAL TYR ASP SEQRES 6 A 69 LEU GLU LEU ASN HELIX 1 1 PRO A 21 ASN A 23 5 3 HELIX 2 2 GLU A 56 LEU A 68 1 13 SHEET 1 A 3 VAL A 25 GLU A 30 0 SHEET 2 A 3 VAL A 40 THR A 44 -1 N VAL A 41 O TYR A 29 SHEET 3 A 3 CYS A 51 ALA A 52 -1 O ALA A 52 N VAL A 40 SSBOND 1 CYS A 11 CYS A 35 1555 1555 2.03 SSBOND 2 CYS A 12 CYS A 51 1555 1555 2.03 CRYST1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000